Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02071862
Title Study of the Glutaminase Inhibitor CB-839 in Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Calithera Biosciences, Inc
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
UCSF Helen Diller Family Comprehensive Cancer Center San Francisco California 94143 United States Details
Stanford University Medical Center Stanford California 94305 United States Details
Florida Cancer Specialists Sarasota Florida 34232 United States Details
Winship Cancer Institute of Emory School of Medicine Atlanta Georgia 30322 United States Details
NIH - NCI - Center for Cancer Research Bethesda Maryland 20892 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
Columbia University Medical Center New York New York 10032 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
University of Pennsylvania, Abramson Cancer Center Philadelphia Pennsylvania 19104 United States Details
Tennessee Oncology, PLLC Nashville Tennessee 37203 United States Details
University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field